Prospective evaluation of concomitant lymphadenectomy in robot-assisted radical prostatectomy: Preliminary analysis of outcomes

Journal of Endourology

Volumn 20, Issue 7, 2006, Pages 514-518

  Atug, Fatih ^a   Castle, Erik P ^a   Srivastav, Sudesh K ^b   Burgess, Scott V ^a   Thomas, Raju ^a   Davis, Rodney ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; EVALUATION; HEALTH CARE COST; HUMAN; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ROBOT ASSISTED RADICAL PROSTATECTOMY; ROBOTICS;

AGED; COSTS AND COST ANALYSIS; HUMANS; LENGTH OF STAY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; TREATMENT OUTCOME;

EID: 33746826019     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.20.514     Document Type: Article

References (20)

1. Link RE, Morton RA. Indications for pelvic lymphadenectomy in prostate cancer. Urol Clin North Am 2001;28:491-498.
2. Bluestein DL, Bostwick DG, Bergstralh EJ, et al. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994;151:1315-1320.
3. Bishoff JT, Reyes A, Thompson IM, et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: Development of a system of patient selection. Urology 1995;45:270-274.
4. Bangma CH, Hop WC, Schroder FH. Eliminating the need for perioperative frozen section analysis of pelvic lymph nodes during radical prostatectomy. Br J Urol 1995;76:595-599.
5. Hoenig DM, Chi S, Porter C, et al. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer. J Endourol 1997;11:263-265.
6. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445-1451.
7. El-Galley RE, Keane TE, Petros JA, et al. Evaluation of staging lymphadenectomy in prostate cancer. Urology 1998;52:663-667.
8. Clavien PA, Sanabria IR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518.
9. Parker CC, Husband J, Dearnaley DP. Lymph node staging in clinically localized prostate cancer. Prostate Cancer Prostatic Dis 1999;2:191-199.
10. Hammerer P, Huland H, Sparenberg A. Digital rectal examination, imaging and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinoma. Eur Urol 1992;22:281-287.
11. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy: The Johns Hopkins' experience after 10 years. Urol Clin North Am 1993;20:713-725.
12. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE Jr, Scardino PT. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989;142:332-336.
13. Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001;166:416-419.
14. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy: Is there a chance of cure? J Urol 2003;169:849-854.
15. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer. J Urol 2004;172:1840-1844.
16. Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER Jr, Wells N, Smith JA Jr. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003;169:145-147.
17. Kavoussi LR, Sosa E, Chandhoke P, et al. Complications of laparoscopic pelvic lymph node dissection. J Urol 1993;149:322-325.
18. Solberg A, Angelsen A, Bergan U, Haugen OA, Viset T, Klepp O. Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol 2003;37:218-221.
19. Guillonneau B, Cappele O, Martinez JB, Navarra S, Vallancien G. Robotic assisted, laparoscopic pelvic lymph node dissection in humans. J Urol 2001;165:1078-1081.
20. Link RE, Su LM, Bhayani SB, Pavlovich CP. Making ends meet: A cost comparison of laparoscopic and open radical retropubic prostatectomy. J Urol 2004;172:269-274.